Global Depressive Disorder Market Research Report 2023

Report ID: 1994692 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Depressive Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Tricyclic Antidepressants
        1.2.3 Selective Serotonin Reuptake Inhibitors
        1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors
        1.2.5 Monoamine Oxidase Inhibitors
        1.2.6 Serotonin Antagonist And Reuptake Inhibitors
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Depressive Disorder Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
        1.3.5 Homecare Settings
        1.3.6 Long Term Care Centers
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Depressive Disorder Market Perspective (2018-2029)
    2.2 Depressive Disorder Growth Trends by Region
        2.2.1 Global Depressive Disorder Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Depressive Disorder Historic Market Size by Region (2018-2023)
        2.2.3 Depressive Disorder Forecasted Market Size by Region (2024-2029)
    2.3 Depressive Disorder Market Dynamics
        2.3.1 Depressive Disorder Industry Trends
        2.3.2 Depressive Disorder Market Drivers
        2.3.3 Depressive Disorder Market Challenges
        2.3.4 Depressive Disorder Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Depressive Disorder Players by Revenue
        3.1.1 Global Top Depressive Disorder Players by Revenue (2018-2023)
        3.1.2 Global Depressive Disorder Revenue Market Share by Players (2018-2023)
    3.2 Global Depressive Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Depressive Disorder Revenue
    3.4 Global Depressive Disorder Market Concentration Ratio
        3.4.1 Global Depressive Disorder Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Depressive Disorder Revenue in 2022
    3.5 Depressive Disorder Key Players Head office and Area Served
    3.6 Key Players Depressive Disorder Product Solution and Service
    3.7 Date of Enter into Depressive Disorder Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Depressive Disorder Breakdown Data by Type
    4.1 Global Depressive Disorder Historic Market Size by Type (2018-2023)
    4.2 Global Depressive Disorder Forecasted Market Size by Type (2024-2029)
5 Depressive Disorder Breakdown Data by Application
    5.1 Global Depressive Disorder Historic Market Size by Application (2018-2023)
    5.2 Global Depressive Disorder Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Depressive Disorder Market Size (2018-2029)
    6.2 North America Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Depressive Disorder Market Size by Country (2018-2023)
    6.4 North America Depressive Disorder Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Depressive Disorder Market Size (2018-2029)
    7.2 Europe Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Depressive Disorder Market Size by Country (2018-2023)
    7.4 Europe Depressive Disorder Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Depressive Disorder Market Size (2018-2029)
    8.2 Asia-Pacific Depressive Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Depressive Disorder Market Size by Region (2018-2023)
    8.4 Asia-Pacific Depressive Disorder Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Depressive Disorder Market Size (2018-2029)
    9.2 Latin America Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Depressive Disorder Market Size by Country (2018-2023)
    9.4 Latin America Depressive Disorder Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Depressive Disorder Market Size (2018-2029)
    10.2 Middle East & Africa Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Depressive Disorder Market Size by Country (2018-2023)
    10.4 Middle East & Africa Depressive Disorder Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Alkermes
        11.1.1 Alkermes Company Detail
        11.1.2 Alkermes Business Overview
        11.1.3 Alkermes Depressive Disorder Introduction
        11.1.4 Alkermes Revenue in Depressive Disorder Business (2018-2023)
        11.1.5 Alkermes Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Depressive Disorder Introduction
        11.2.4 Allergan Revenue in Depressive Disorder Business (2018-2023)
        11.2.5 Allergan Recent Development
    11.3 Bristol Myers Squibb
        11.3.1 Bristol Myers Squibb Company Detail
        11.3.2 Bristol Myers Squibb Business Overview
        11.3.3 Bristol Myers Squibb Depressive Disorder Introduction
        11.3.4 Bristol Myers Squibb Revenue in Depressive Disorder Business (2018-2023)
        11.3.5 Bristol Myers Squibb Recent Development
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Detail
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Depressive Disorder Introduction
        11.4.4 Eli Lilly Revenue in Depressive Disorder Business (2018-2023)
        11.4.5 Eli Lilly Recent Development
    11.5 Glaxosmithkline
        11.5.1 Glaxosmithkline Company Detail
        11.5.2 Glaxosmithkline Business Overview
        11.5.3 Glaxosmithkline Depressive Disorder Introduction
        11.5.4 Glaxosmithkline Revenue in Depressive Disorder Business (2018-2023)
        11.5.5 Glaxosmithkline Recent Development
    11.6 H. Lundbeck
        11.6.1 H. Lundbeck Company Detail
        11.6.2 H. Lundbeck Business Overview
        11.6.3 H. Lundbeck Depressive Disorder Introduction
        11.6.4 H. Lundbeck Revenue in Depressive Disorder Business (2018-2023)
        11.6.5 H. Lundbeck Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Depressive Disorder Introduction
        11.7.4 Merck Revenue in Depressive Disorder Business (2018-2023)
        11.7.5 Merck Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Depressive Disorder Introduction
        11.8.4 Pfizer Revenue in Depressive Disorder Business (2018-2023)
        11.8.5 Pfizer Recent Development
    11.9 Teva Pharmaceutical
        11.9.1 Teva Pharmaceutical Company Detail
        11.9.2 Teva Pharmaceutical Business Overview
        11.9.3 Teva Pharmaceutical Depressive Disorder Introduction
        11.9.4 Teva Pharmaceutical Revenue in Depressive Disorder Business (2018-2023)
        11.9.5 Teva Pharmaceutical Recent Development
    11.10 Takeda Pharmaceutical
        11.10.1 Takeda Pharmaceutical Company Detail
        11.10.2 Takeda Pharmaceutical Business Overview
        11.10.3 Takeda Pharmaceutical Depressive Disorder Introduction
        11.10.4 Takeda Pharmaceutical Revenue in Depressive Disorder Business (2018-2023)
        11.10.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Depressive Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Tricyclic Antidepressants
    Table 3. Key Players of Selective Serotonin Reuptake Inhibitors
    Table 4. Key Players of Serotonin-Norepinephrine Reuptake Inhibitors
    Table 5. Key Players of Monoamine Oxidase Inhibitors
    Table 6. Key Players of Serotonin Antagonist And Reuptake Inhibitors
    Table 7. Key Players of Others
    Table 8. Global Depressive Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Depressive Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Depressive Disorder Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Depressive Disorder Market Share by Region (2018-2023)
    Table 12. Global Depressive Disorder Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Depressive Disorder Market Share by Region (2024-2029)
    Table 14. Depressive Disorder Market Trends
    Table 15. Depressive Disorder Market Drivers
    Table 16. Depressive Disorder Market Challenges
    Table 17. Depressive Disorder Market Restraints
    Table 18. Global Depressive Disorder Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Depressive Disorder Market Share by Players (2018-2023)
    Table 20. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depressive Disorder as of 2022)
    Table 21. Ranking of Global Top Depressive Disorder Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Depressive Disorder Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Depressive Disorder Product Solution and Service
    Table 25. Date of Enter into Depressive Disorder Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Depressive Disorder Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Depressive Disorder Revenue Market Share by Type (2018-2023)
    Table 29. Global Depressive Disorder Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Depressive Disorder Revenue Market Share by Type (2024-2029)
    Table 31. Global Depressive Disorder Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Depressive Disorder Revenue Market Share by Application (2018-2023)
    Table 33. Global Depressive Disorder Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Depressive Disorder Revenue Market Share by Application (2024-2029)
    Table 35. North America Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Depressive Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Depressive Disorder Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Depressive Disorder Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Alkermes Company Detail
    Table 51. Alkermes Business Overview
    Table 52. Alkermes Depressive Disorder Product
    Table 53. Alkermes Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 54. Alkermes Recent Development
    Table 55. Allergan Company Detail
    Table 56. Allergan Business Overview
    Table 57. Allergan Depressive Disorder Product
    Table 58. Allergan Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 59. Allergan Recent Development
    Table 60. Bristol Myers Squibb Company Detail
    Table 61. Bristol Myers Squibb Business Overview
    Table 62. Bristol Myers Squibb Depressive Disorder Product
    Table 63. Bristol Myers Squibb Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 64. Bristol Myers Squibb Recent Development
    Table 65. Eli Lilly Company Detail
    Table 66. Eli Lilly Business Overview
    Table 67. Eli Lilly Depressive Disorder Product
    Table 68. Eli Lilly Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 69. Eli Lilly Recent Development
    Table 70. Glaxosmithkline Company Detail
    Table 71. Glaxosmithkline Business Overview
    Table 72. Glaxosmithkline Depressive Disorder Product
    Table 73. Glaxosmithkline Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 74. Glaxosmithkline Recent Development
    Table 75. H. Lundbeck Company Detail
    Table 76. H. Lundbeck Business Overview
    Table 77. H. Lundbeck Depressive Disorder Product
    Table 78. H. Lundbeck Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 79. H. Lundbeck Recent Development
    Table 80. Merck Company Detail
    Table 81. Merck Business Overview
    Table 82. Merck Depressive Disorder Product
    Table 83. Merck Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 84. Merck Recent Development
    Table 85. Pfizer Company Detail
    Table 86. Pfizer Business Overview
    Table 87. Pfizer Depressive Disorder Product
    Table 88. Pfizer Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 89. Pfizer Recent Development
    Table 90. Teva Pharmaceutical Company Detail
    Table 91. Teva Pharmaceutical Business Overview
    Table 92. Teva Pharmaceutical Depressive Disorder Product
    Table 93. Teva Pharmaceutical Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 94. Teva Pharmaceutical Recent Development
    Table 95. Takeda Pharmaceutical Company Detail
    Table 96. Takeda Pharmaceutical Business Overview
    Table 97. Takeda Pharmaceutical Depressive Disorder Product
    Table 98. Takeda Pharmaceutical Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
    Table 99. Takeda Pharmaceutical Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Depressive Disorder Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Depressive Disorder Market Share by Type: 2022 VS 2029
    Figure 3. Tricyclic Antidepressants Features
    Figure 4. Selective Serotonin Reuptake Inhibitors Features
    Figure 5. Serotonin-Norepinephrine Reuptake Inhibitors Features
    Figure 6. Monoamine Oxidase Inhibitors Features
    Figure 7. Serotonin Antagonist And Reuptake Inhibitors Features
    Figure 8. Others Features
    Figure 9. Global Depressive Disorder Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Depressive Disorder Market Share by Application: 2022 VS 2029
    Figure 11. Hospitals Case Studies
    Figure 12. Ambulatory Surgical Centers Case Studies
    Figure 13. Diagnostic Centers Case Studies
    Figure 14. Homecare Settings Case Studies
    Figure 15. Long Term Care Centers Case Studies
    Figure 16. Depressive Disorder Report Years Considered
    Figure 17. Global Depressive Disorder Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 18. Global Depressive Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 19. Global Depressive Disorder Market Share by Region: 2022 VS 2029
    Figure 20. Global Depressive Disorder Market Share by Players in 2022
    Figure 21. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depressive Disorder as of 2022)
    Figure 22. The Top 10 and 5 Players Market Share by Depressive Disorder Revenue in 2022
    Figure 23. North America Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. North America Depressive Disorder Market Share by Country (2018-2029)
    Figure 25. United States Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Canada Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Europe Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Europe Depressive Disorder Market Share by Country (2018-2029)
    Figure 29. Germany Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Asia-Pacific Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Asia-Pacific Depressive Disorder Market Share by Region (2018-2029)
    Figure 37. China Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Japan Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. South Korea Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Southeast Asia Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. India Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Australia Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Latin America Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Latin America Depressive Disorder Market Share by Country (2018-2029)
    Figure 45. Mexico Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Brazil Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Middle East & Africa Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Depressive Disorder Market Share by Country (2018-2029)
    Figure 49. Turkey Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Saudi Arabia Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Alkermes Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 52. Allergan Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 53. Bristol Myers Squibb Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 54. Eli Lilly Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 55. Glaxosmithkline Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 56. H. Lundbeck Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 57. Merck Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 58. Pfizer Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 59. Teva Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 60. Takeda Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2018-2023)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
Glaxosmithkline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical
Takeda Pharmaceutical
Frequently Asked Questions
Depressive Disorder report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Depressive Disorder report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Depressive Disorder report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Erythropoietin (EPO)

This report aims to provide a comprehensive presentation of the global market for Erythropoietin  ... Read More